Rhythm Pharmaceuticals Announces Additional Positive Data from Phase 3 TRANSCEND trial of Setmelanotide in Patients with Acquired Hypothalamic Obesity
-- -18.8% placebo-adjusted difference in BMI reduction achieved in all patients (N=142)…
Celldex Presents Positive Data Demonstrating Barzolvolimab Retreatment Achieves Similar Profound Efficacy to First Exposure in Patients with Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Further Demonstrating First-in-Class and Best-in-Disease
March 01, 2026 09:45 ET | Source: Celldex Therapeutics, Inc. - Late…
Nokia and Ericsson strengthen cooperation to accelerate towards Autonomous Networks
Press Release Nokia and Ericsson strengthen cooperation to accelerate towards Autonomous Networks …
Nokia accelerates AI-RAN momentum with new partnerships driving path to AI-Native 6G #MWC26
Press Release Nokia accelerates AI-RAN momentum with new partnerships driving path to…
Nokia expands network portfolio for premium performance in the AI-RAN era #MWC26
Press Release Nokia expands network portfolio for premium performance in the AI-RAN…
CARLSBERG MAKES EVERY FAN FEEL PART OF MATCHDAY WITH BSL RENDITION OF “YOU’LL NEVER WALK ALONE”
COPENHAGEN, Denmark, Feb. 28, 2026 /PRNewswire/ -- Carlsberg and its long standing…
CARLSBERG MAKES EVERY FAN FEEL PART OF MATCHDAY WITH BRITISH SIGN LANGUAGE RENDITION OF ‘YOU’LL NEVER WALK ALONE’
COPENHAGEN, Denmark, March. 1 2026 /PRNewswire/ -- Carlsberg and its long standing…
Guide Redefines Thermal Excellence at IWA OutdoorClassics 2026
NÜRNBERG, Germany, March 1, 2026 /PRNewswire/ -- Guide, a leader in infrared…
Xinhua Silk Road: Dehua unveils three visions in Geneva, promoting cultural exchange and industrial cooperation
BEIJING, Feb. 28, 2026 /PRNewswire/ -- More than 30 fine Dehua white…
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting
Châtillon, France, February 28, 2026 DBV Technologies Highlights Additional Data from Successful…
